Walther EU - Search Results

1

[Formation of neutralizing antibodies in therapy of multiple sclerosis with interferon beta-1b. Practical procedure in suspected therapeutic failure].

Walther EU, Dang T, Hartung HP, Hohlfeld R. Walther EU, et al. Nervenarzt. 1997 Dec;68(12):935-9. doi: 10.1007/s001150050219. Nervenarzt. 1997. PMID: 9465334 Review. German.

2

[Therapy of multiple sclerosis with interferon-beta-1b. Educating the patient and managing side-effects].

Walther EU, Dietrich E, Hohlfeld R. Walther EU, et al. Nervenarzt. 1996 Jun;67(6):452-6. Nervenarzt. 1996. PMID: 8767199 Review. German.

3

[Interferon beta-1b for treatment of secondary chronic progressive multiple sclerosis].

Zimmermann C, Walther EU, Goebels N, Lienert C, Kappos L, Hartung HP, Hohlfeld R. Zimmermann C, et al. Among authors: walther eu. Nervenarzt. 1999 Aug;70(8):759-63. doi: 10.1007/s001150050508. Nervenarzt. 1999. PMID: 10483579 Clinical Trial. German.

4

[Interferon beta-1b (Betaferon)therapy in patients with relapsing-remitting multiple sclerosis: findings of a prospective, multi-center study of disease progression].

Oentrich W, Dose T, Friedmann D, Haupts M, Haller P, Hartung HP, Walther EU, König N, Schröder G, Stürzebecher CS. Oentrich W, et al. Among authors: walther eu. Nervenarzt. 2001 Apr;72(4):286-92. doi: 10.1007/s001150050752. Nervenarzt. 2001. PMID: 11320864 German.

5

Multiple sclerosis: side effects of interferon beta therapy and their management.

Walther EU, Hohlfeld R. Walther EU, et al. Neurology. 1999 Nov 10;53(8):1622-7. doi: 10.1212/wnl.53.8.1622. Neurology. 1999. PMID: 10563602 Review.

6

[Therapy of multiple sclerosis].

Bereznai B, Goebels N, Dang T, Voltz R, Walther E, Zimmermann C, Hohlfeld R. Bereznai B, et al. Dtsch Med Wochenschr. 1999 May 14;124(19):595-9. doi: 10.1055/s-2007-1024374. Dtsch Med Wochenschr. 1999. PMID: 10365178 Review. German. No abstract available.

7

[Gliomatosis cerebri: two case reports with atypical clinical and neuroradiologic findings].

Reich P, Walther EU, Liebetrau M, Seelos K, Yousry TA, Bise K, Bötzel K, Pfister HW. Reich P, et al. Among authors: walther eu. Nervenarzt. 2000 Jun;71(6):481-4. doi: 10.1007/s001150050611. Nervenarzt. 2000. PMID: 10919144 Review. German.

8

Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis.

Yousry TA, Fesl G, Walther E, Voltz R, Filippi M. Yousry TA, et al. J Neurol Sci. 1998 Jun 30;158(2):221-5. doi: 10.1016/s0022-510x(98)00114-2. J Neurol Sci. 1998. PMID: 9702695

9

Closed- and open-loop handwriting performance in patients with multiple sclerosis.

Schenk T, Walther EU, Mai N. Schenk T, et al. Among authors: walther eu. Eur J Neurol. 2000 May;7(3):269-79. doi: 10.1046/j.1468-1331.2000.00068.x. Eur J Neurol. 2000. PMID: 10886310

10

Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose.

Yousry I, Filippi M, Walther E, Gasperini C, Capra R, Yousry TA. Yousry I, et al. Magn Reson Imaging. 2000 Nov;18(9):1183-6. doi: 10.1016/s0730-725x(00)00191-0. Magn Reson Imaging. 2000. PMID: 11118774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters